Merck is the first company to report trial results of a pill to treat Covid ... molnupiravir by the end of 2021. The US government has already agreed to buy $1.2bn (£885m) worth of the drug ...
But US authorities recently made an advance purchase of 1.7 million ... also made purchase agreements. Merck is the first company to report trial results of a pill to treat Covid, but other ...
Earlier this year, the Sun Pharma had signed a non-exclusive voluntary licensing agreement with US-based Merck to manufacture ... advantage as it reduces the pill burden and enhances compliance.
U.S. regulators on Thursday authorized the Merck pill for certain high-risk adult patients. Countries rushed to buy Merck's molnupiravir after very promising initial results, but subsequent ...
The company paid US$200 per share, more than 70% above the Prometheus's closing share price on April 14, before the acquisition was announced on April 16. The majority of the offering contains special ...
The US government has placed an order with Merck & Co to buy 1.7 million courses of its antiviral therapy molnupiravir for COVID-19, assuming it gets approved for use by the FDA. The $1.2 billion ...
WASHINGTON--A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck ... the government’s purchase agreement with Merck for 3.1 million courses ...